GetTopicDetailResponse(id=3ed416940f2, topicName=suvorexant, introduction=suvorexant, content=null, image=null, comments=5, allHits=1189, url=https://h5.medsci.cn/topic?id=16940, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=4605, tagList=[TagDto(tagId=4605, tagName=suvorexant)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1984801, encodeId=970019848014e, content=<a href='/topic/show?id=3ed416940f2' target=_blank style='color:#2F92EE;'>#suvorexant#</a>, objectTitle=Alzheimers Dement：Suvorexant可改善疑似AD癡呆和失眠患者的睡眠情況, objectType=article, longId=204202, objectId=6578204202b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6578204202b8, replyNumber=0, likeNumber=82, createdTime=2021-11-19, rootId=0, userName=12498636m49(暫無昵稱), userId=e2c92500045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6578204202b8, moduleTitle=Alzheimers Dement：Suvorexant可改善疑似AD癡呆和失眠患者的睡眠情況, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6578204202b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984800, encodeId=34d9198480005, content=<a href='/topic/show?id=3ed416940f2' target=_blank style='color:#2F92EE;'>#suvorexant#</a>, objectTitle=Biol Psychiatry：Suvorexant可以治療失眠患者, objectType=article, longId=60615, objectId=49f160615e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49f160615e8, replyNumber=0, likeNumber=107, createdTime=2016-08-01, rootId=0, userName=12498636m49(暫無昵稱), userId=e2c92500045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49f160615e8, moduleTitle=Biol Psychiatry：Suvorexant可以治療失眠患者, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=49f160615e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984799, encodeId=ab8c1984e990b, content=<a href='/topic/show?id=3ed416940f2' target=_blank style='color:#2F92EE;'>#suvorexant#</a>, objectTitle=Lancet Neurol：Suvorexant對慢性失眠具有持久療效與良好安全性, objectType=article, longId=34007, objectId=c1233400e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1233400e52, replyNumber=0, likeNumber=94, createdTime=2015-01-08, rootId=0, userName=12498636m49(暫無昵稱), userId=e2c92500045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1233400e52, moduleTitle=Lancet Neurol：Suvorexant對慢性失眠具有持久療效與良好安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1233400e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984797, encodeId=77441984e97e6, content=<a href='/topic/show?id=3ed416940f2' target=_blank style='color:#2F92EE;'>#suvorexant#</a>, objectTitle=MSD失眠癥藥物Suvorexant獲FDA批準希望大增, objectType=article, longId=19376, objectId=329e193e644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=329e193e644, replyNumber=0, likeNumber=87, createdTime=2014-03-08, rootId=0, userName=12498636m49(暫無昵稱), userId=e2c92500045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=329e193e644, moduleTitle=MSD失眠癥藥物Suvorexant獲FDA批準希望大增, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=329e193e644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984798, encodeId=4deb1984e98fe, content=<a href='/topic/show?id=3ed416940f2' target=_blank style='color:#2F92EE;'>#suvorexant#</a>, objectTitle=默沙東失眠新藥suvorexant NDA遭FDA拒絕但低劑量版獲批現(xiàn)曙光, objectType=article, longId=20874, objectId=0bc3208e417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bc3208e417, replyNumber=0, likeNumber=106, createdTime=2014-06-19, rootId=0, userName=12498636m49(暫無昵稱), userId=e2c92500045, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bc3208e417, moduleTitle=默沙東失眠新藥suvorexant NDA遭FDA拒絕但低劑量版獲批現(xiàn)曙光, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0bc3208e417)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
